Biopharma Company Working On Synthetic THC Drug To Treat Anxiety Launches NASDAQ IPO
Pre-clinical-stage biopharma company, MIRA Pharmaceuticals (NASDAQ: MIRA) launched its initial public offering Thursday and is trading $6.72 per share at the time of reporting.
